Scinai Immunotherapeutics Ltd. (SCNI)
0.4844
+0.04
(+9.84%)
USD |
NASDAQ |
Nov 09, 16:00
0.479
-0.01
(-1.11%)
After-Hours: 19:29
Scinai Immunotherapeutics Debt to Equity Ratio : 0.3166 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.3166 |
| June 30, 2026 | 0.3052 |
| March 31, 2026 | 0.2973 |
| December 31, 2025 | 0.2798 |
| September 30, 2025 | |
| June 30, 2025 | 0.2998 |
| March 31, 2025 | |
| December 31, 2024 | 0.2091 |
| September 30, 2024 | 0.1227 |
| June 30, 2024 | -2.859 |
| March 31, 2024 | -4.032 |
| December 31, 2023 | -4.500 |
| September 30, 2023 | -7.358 |
| June 30, 2023 | -3.461 |
| March 31, 2023 | -4.840 |
| September 30, 2022 | 6.627 |
| June 30, 2022 | 17.25 |
| March 31, 2022 | 4.427 |
| December 31, 2021 | 2.989 |
| September 30, 2021 | 17.00 |
| June 30, 2021 | 6.241 |
| March 31, 2021 | 3.315 |
| December 31, 2020 | -4.602 |
| September 30, 2020 | -35.94 |
| June 30, 2020 | -2.086 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | -2.018 |
| September 30, 2019 | -5.675 |
| June 30, 2019 | -1.637 |
| March 31, 2019 | -3.162 |
| December 31, 2018 | -3.023 |
| September 30, 2018 | 2.947 |
| June 30, 2018 | 1.239 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Compugen Ltd. | 0.0341 |
| Pluri, Inc. | -1.516 |
| Evogene Ltd. | -0.6386 |
| CollPlant Biotechnologies Ltd. | 0.9032 |
| Regentis Biomaterials Ltd. | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 15.70M |
| Total Liabilities (Quarterly) | 4.984M |
| Shareholders Equity (Quarterly) | 10.71M |
| Current Ratio | 1.225 |
| Net Debt Paydown Yield | -10.78% |